Role of endogenous glucagon-like peptide-1 in the serum triglyceride response to intraduodenal fat infusion in type 2 diabetic patients on vildagliptin

被引：0
|
作者：
Wu, T. [1 ,2 ]
Xie, C. [1 ]
Wang, X. [1 ,2 ]
Bound, M. J. [1 ]
Grivell, J. [1 ]
Jones, K. L. [1 ]
Horowitz, M. [1 ]
Little, T. J. [1 ]
Rayner, C. K. [1 ]
机构：
[1] Univ Adelaide, Adelaide, SA, Australia
[2] Southeast Univ, Nanjing, Peoples R China
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
579
引用
下载
收藏
页码：S278 / S278
页数：1
相关论文
共 50 条
  • [1] Role of endogenous glucagon-like peptide-1 enhanced by vildagliptin in the glycaemic and energy expenditure responses to intraduodenal fat infusion in type 2 diabetes
    Xie, Cong
    Wang, Xuyi
    Jones, Karen L.
    Horowitz, Michael
    Sun, Zilin
    Little, Tanya J.
    Rayner, Christopher K.
    Wu, Tongzhi
    DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 383 - 392
  • [2] Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects
    DeLeon, MJ
    Chandurkar, V
    Albert, SG
    Mooradian, AD
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 56 (02) : 101 - 106
  • [3] Glucagon-like peptide-1 improves endothelial function in type 2 diabetic patients
    Nyström, T
    Gutniak, M
    Ahrén, B
    Holst, J
    Sjöholm, Å
    DIABETOLOGIA, 2004, 47 : A28 - A28
  • [4] Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
    Toft-Nielsen, MB
    Damholt, MB
    Madsbad, S
    Hilsted, LM
    Hughes, TE
    Michelsen, BK
    Holst, JJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08): : 3717 - 3723
  • [5] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554
  • [6] Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients
    E. Mannucci
    L. Pala
    M. Monami
    L. Vico
    G. Bardini
    I. Dicembrini
    S. Ciani
    C. Lamanna
    N. Marchionni
    C. M. Rotella
    Journal of Endocrinological Investigation, 2010, 33 : 147 - 150
  • [7] Glucagon-like peptide-1 response to meals and post-prandial hyperglycemia in Type 2 diabetic patients
    Mannucci, E.
    Pala, L.
    Monami, M.
    Da Vico, L.
    Bardini, G.
    Dicembrini, I.
    Ciani, S.
    Lamanna, C.
    Marchionni, N.
    Rotella, C. M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2010, 33 (03) : 147 - 150
  • [8] Inhibition of human gastric lipase by intraduodenal fat involves glucagon-like peptide-1 and cholecystokinin
    Wojdemann, M
    Riber, C
    Bisgaard, T
    Sternby, B
    Larsen, S
    Rehfeld, JF
    Holst, JJ
    Olsen, O
    REGULATORY PEPTIDES, 1999, 80 (03) : 101 - 106
  • [9] Role of Fat Hydrolysis in Regulating Glucagon-Like Peptide-1 Secretion
    Beglinger, Svetlana
    Drewe, Juergen
    Schirra, Joerg
    Goeke, Burkhard
    D'Amato, Massimo
    Beglinger, Christoph
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02): : 879 - 886
  • [10] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
12345